Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,736.85
(
-0.02%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: DewDiligence post# 153764

Monday, 12/30/2013 10:38:18 AM

Monday, December 30, 2013 10:38:18 AM

Post# of 347009
Patients requesting Bavi under "compassionate use" could be quite the shocker to the FDA. Imagine if they revealed the top 10 most requested drug for compassionate use?

As for early enrollment...it may be the case where several : ) Drs are receiving high interest in this "SunRise" trial but would have no option but to tell those patients just wait till it starts...

Its started .... and guess those preferred shares will become a big issue with Big Pharma in a few years when the true value is revealed.

A 1000 shares today will make one hell of a biotech value in just under 3 years time...."astronomical" comes to mind.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote